• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ALLEN W. ROOT, MD

Am J Dis Child. 1992;146(9):1029-1030.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Blizzard et al¹ were among the first to suggest that maternal autoimmune thyroid disease (AITD) may be of pathogenic significance in the development of neonatal hypothyroidism. Matsuura et al² first described the occurrence of transient neonatal hypothyroidism due to the transplacental passage of maternal immunoglobulins that inhibited the binding of thyrotropin to its receptor on the thyrotrope membrane. Since then, the role of AITD in the pathogenesis of both transient and permanent forms of this disorder has been subjected to renewed investigation. Many antibodies of diverse biological activity have been found in the serum samples of women with known or subclinical AITD who have delivered infants with neonatal hypothyroidism. These include IgGs that: (1) inhibit binding of thyrotropin to its receptor (TBIIg, measured in a radioreceptor assay), (2) inhibit thyrotropin-mediated growth of thyroid cells (TGIIg, assessed by the effect of serum immunoglobulins on thyrotropin-induced increase in nuclear DNA . . . [Full Text PDF of this Article]

Author Affiliations

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?